Digital Opinion Leaders (DOLs) and KOLs overlap, but each group is unique. Unlike traditional KOLs, DOLs have a different reach and a unique voice because they know how to effectively use multiple
Alnylam has been a pioneer in hereditary ATTR amyloidosis, getting approval in 2018 for the first drug to treat the rare disease, and has now launched a digital companion to help patients t
A data-mining study conducted by researchers in the US has found that an already-approved diuretic drug could have potential as a treatment for some patients with Alzheimer's disease.
Limbix is moving ahead with plans to file for FDA approval of its SparkRx digital therapeutic (DTx) for adolescents with symptoms of depression after reporting positive results in a clinica
The developer of a toolkit that promises to create a "digital twin" of individuals with chronic metabolic diseases like diabetes to help model the impact of lifestyle changes has secured $1